Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

309 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H. Sakamoto J, et al. Among authors: teramukai s. Cancer. 1996 Jun 1;77(11):2206-12. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2206::AID-CNCR4>3.0.CO;2-N. Cancer. 1996. PMID: 8635085
Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan.
Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, Toge T, Okura H, Kodaira S, Maetani S, Okajima K, Nomoto K, Hattori T, Inokuchi K. Sakamoto J, et al. Among authors: teramukai s. Surg Oncol. 1996 Jun;5(3):133-9. doi: 10.1016/s0960-7404(96)80013-2. Surg Oncol. 1996. PMID: 8908719
Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, Ohashi Y, Nakazato H. Saji S, et al. Among authors: teramukai s. Surg Today. 1999;29(6):504-10. doi: 10.1007/BF02482344. Surg Today. 1999. PMID: 10385364 Clinical Trial.
309 results